A pilot study to evaluate feasibility and safety of early switch to everolimus from cyclosporine in de novo renal transplant.

Trial Profile

A pilot study to evaluate feasibility and safety of early switch to everolimus from cyclosporine in de novo renal transplant.

Completed
Phase of Trial: Phase III

Latest Information Update: 06 May 2014

At a glance

  • Drugs Everolimus (Primary)
  • Indications Renal transplant rejection
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 06 Mar 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 01 Nov 2011 Planned end date Jul 2007 as reported by ClinicalTrials.gov.
    • 07 Jul 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top